Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System
Authors:
Top Cited Papers
- 1 March 2021
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 14 (5) , 501-511
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
- Abbott Vascular
- Edwards Lifesciences
This publication has 26 references indexed in Scilit:
- First-in-Human Implantations of the NaviGate Bioprosthesis in a Severely Dilated Tricuspid Annulus and in a Failed Tricuspid Annuloplasty RingCirculation: Cardiovascular Interventions, 2017
- National Trends and Outcomes in Isolated Tricuspid Valve SurgeryJACC, 2017
- The need for a new tricuspid regurgitation grading schemeEuropean Heart Journal - Cardiovascular Imaging, 2017
- Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker LeadsThe American Journal of Cardiology, 2016
- One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registryEuropean Heart Journal, 2015
- Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitionsEuropean Heart Journal, 2015
- Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve ReplacementCirculation, 2015
- Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-upHeart, 2014
- Tricuspid Regurgitation in Patients With Pacemakers and Implantable Cardiac Defibrillators: A Comprehensive ReviewClinical Cardiology, 2013
- Impact of tricuspid regurgitation on long-term survivalJACC, 2004